{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:36:11Z","timestamp":1790789771641,"version":"4.1.0"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T00:00:00Z","timestamp":1335398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002671","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T21:07:20Z","timestamp":1336079240000},"page":"e1002671","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Macrophage Activation Associated with Chronic Murine Cytomegalovirus Infection Results in More Severe Experimental Choroidal Neovascularization"],"prefix":"10.1371","volume":"8","author":[{"given":"Scott W.","family":"Cousins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego G.","family":"Espinosa-Heidmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pereira-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleut P.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Meier-Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Dix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease.","volume":"352","author":"GK Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","article-title":"Infiltration of COX-2-expressing macrophages as a prerequisite for IL-1 beta-induced neovascularization and tumor growth.","volume":"115","author":"S Nakao","year":"2005","journal-title":"J Clin Invest"},{"key":"ref3","first-page":"23","article-title":"Endogenous angiogenesis inhibitors in diabetic retinopathy.","author":"J-X Ma","year":"2006"},{"key":"ref4","first-page":"309","article-title":"Anti-VEGF therapies for diseases of the retina and choroid.","author":"M Lu","year":"2006"},{"key":"ref5","first-page":"3","article-title":"Age-related macular degeneration.","author":"CL Hagedorn","year":"2006"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy. The Beaver Dam Eye Study.","volume":"99","author":"R Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(97)30368-6","article-title":"The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.","volume":"104","author":"R Klein","year":"1997","journal-title":"Ophthalmology"},{"key":"ref8","article-title":"Vision problems in the U.S. A report on blindness and vision impairment in adults age 40 and older.","author":"JA Tielsch","year":"1995"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(95)31034-2","article-title":"The prevalence of age-related maculopathy in the Rotterdam Study.","volume":"102","author":"JR Vingerling","year":"1995","journal-title":"Ophthalmology"},{"key":"ref10","first-page":"213","article-title":"Age-related macular degeneration.","author":"SR O'Connell","year":"1999"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration.","volume":"308","author":"AO Edwards","year":"2005","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration.","volume":"308","author":"JL Haines","year":"2005","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration.","volume":"308","author":"RJ Klein","year":"2005","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/431426","article-title":"Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.","volume":"77","author":"S Zareparsi","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref15","first-page":"26","article-title":"Immunology of age-related macular degeneration.","author":"S Cousins","year":"2005"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1350-9462(00)00025-2","article-title":"Immunological and aetiological aspects of macular degeneration.","volume":"20","author":"PL Penfold","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"ref17","first-page":"119","article-title":"Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.","volume":"8","author":"HE Grossniklaus","year":"2002","journal-title":"Mol Vis"},{"issue":"Pt 4","key":"ref18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/eye.1990.86","article-title":"Macrophages related to Bruch's membrane in age-related macular degeneration.","volume":"4","author":"MC Killingsworth","year":"1990","journal-title":"Eye (Lond)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization.","volume":"44","author":"DG Espinosa-Heidmann","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization.","volume":"44","author":"E Sakurai","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages.","volume":"3","author":"S Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jlb.55.3.410","article-title":"Macrophages and angiogenesis.","volume":"55","author":"C Sunderkotter","year":"1994","journal-title":"J Leukoc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation.","volume":"73","author":"DM Mosser","year":"2003","journal-title":"J Leuk Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","article-title":"Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?","volume":"122","author":"SW Cousins","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization.","volume":"13","author":"FO Martinez","year":"2008","journal-title":"Front Biosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age.","volume":"23","author":"A Mantovani","year":"2005","journal-title":"Immunity"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.","volume":"42","author":"A Sica","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1570161052773861","article-title":"Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.","volume":"3","author":"JJ Boyle","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1155\/S1064744999000137","article-title":"Chlamydial heat shock proteins and disease pathology: new paradigms for old problems?","volume":"7","author":"D LaVerda","year":"1999","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.micinf.2004.05.020","article-title":"Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis.","volume":"6","author":"I Vliegen","year":"2004","journal-title":"Microbes Infect"},{"key":"ref31","first-page":"249","article-title":"The role of the infectious agents in the pathogenesis and evolution of atherosclerosis.","volume":"19","author":"C Blasi","year":"2004","journal-title":"Ann Ital Med Int"},{"key":"ref32","first-page":"960","article-title":"Infectious and inflammatory factors in the etiology and pathogenesis of atherosclerosis.","volume":"49","author":"M Andel","year":"2003","journal-title":"Vnitr Lek"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/14017430050142341","article-title":"Infections and atherosclerosis.","volume":"34","author":"M Leinonen","year":"2000","journal-title":"Scand Cardiovasc J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00129784-200202020-00004","article-title":"Secondary prevention of coronary artery disease with antimicrobials: current status and future directions.","volume":"2","author":"JB Muhlestein","year":"2002","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajo.2004.03.018","article-title":"The association of prior cytomegalovirus infection with neovascular age-related macular degeneration.","volume":"138","author":"DM Miller","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00417-005-1169-y","article-title":"Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration.","volume":"243","author":"MV Kalayoglu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/02713680490504641","article-title":"AIDS-related cytomegalovirus retinitis: lessons from the laboratory.","volume":"29","author":"RD Dix","year":"2004","journal-title":"Curr Eye Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1574-6976.1999.tb00408.x","article-title":"The pathogenicity of cytomegalovirus.","volume":"23","author":"C Sweet","year":"1999","journal-title":"FEMS Microbiol Rev"},{"key":"ref39","first-page":"1567","article-title":"Age as an independent risk factor for severity of experimental choroidal neovascularization.","volume":"43","author":"DG Espinosa-Heidmann","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/JVI.72.1.95-103.1998","article-title":"Cellular localization of latent murine cytomegalovirus.","volume":"72","author":"AJ Koffron","year":"1998","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.134.2.335","article-title":"Infection and transformation of mouse peritoneal macrophages by simian virus 40.","volume":"134","author":"J Mauel","year":"1971","journal-title":"J Exper Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virusres.2010.11.004","article-title":"The search for new therapies for human cytomegalovirus infections.","volume":"157","author":"MN Prichard","year":"2011","journal-title":"Virus Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/AAC.45.5.1444-1449.2001","article-title":"Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.","volume":"45","author":"JC Lenzo","year":"2001","journal-title":"Antimicrob Agents Chemther"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-047-8","article-title":"Ocular angiogenesis: Diseases, mechanisms and therapeutics","author":"J Tombran-Tink","year":"2006"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm.","volume":"164","author":"CD Mills","year":"2000","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000055488","article-title":"Systemic murine cytomegalovirus infection of mice with retrovirus-induced immunodeficiency (MAIDS) results in ocular infection but not retinitis.","volume":"30","author":"RD Dix","year":"1998","journal-title":"Ophthalmic Res"},{"key":"ref47","first-page":"350","article-title":"Infectious agents and atherosclerosis: current perspectives and unsolved issues.","volume":"5","author":"A Kol","year":"2004","journal-title":"Ital Heart J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","article-title":"Inflammatory mediators in the elderly.","volume":"39","author":"KS Krabbe","year":"2004","journal-title":"Exp Gerontol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1189\/jlb.1203605","article-title":"Immunopathogenesis of atherosclerosis.","volume":"76","author":"B Ludewig","year":"2004","journal-title":"J Leukoc Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1601-0825.2000.tb00126.x","article-title":"Periodontal infections and cardiovascular disease \u2013how strong is the association?","volume":"6","author":"GC Armitage","year":"2000","journal-title":"Oral Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1902\/annals.2001.6.1.1","article-title":"The relationship between infection, inflammation, and cardiovascular disease: an overview.","volume":"6","author":"GD Lowe","year":"2001","journal-title":"Ann Periodontol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.virusres.2010.09.011","article-title":"The role of cytomegalovirus in angiogenesis.","volume":"157","author":"P Caposio","year":"2011","journal-title":"Virus Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.virusres.2010.10.026","article-title":"Is HCMV a tumor promotor?","volume":"157","author":"S Liliana","year":"2011","journal-title":"Virus Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0140-6736(83)92529-1","article-title":"Cytomegalovirus antigen within human arterial smooth muscle cells.","volume":"2","author":"JL Melnick","year":"1983","journal-title":"Lancet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.102.16.1917","article-title":"Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.","volume":"102","author":"JB Muhlestein","year":"2000","journal-title":"Circulation"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1386-6532(99)00064-5","article-title":"The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis.","volume":"16","author":"R Horvath","year":"2000","journal-title":"J Clin Virol"},{"key":"ref57","first-page":"71","article-title":"Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques.","volume":"8","author":"HB Qavi","year":"2000","journal-title":"Cent Eur J Public Health"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(00)00608-0","article-title":"Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice.","volume":"156","author":"E Hsich","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref59","first-page":"397","article-title":"Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.","volume":"325","author":"DN Streblow","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.micinf.2003.09.024","article-title":"Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation.","volume":"6","author":"I Vliegen","year":"2004","journal-title":"Microbes Infect"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.micinf.2004.05.020","article-title":"Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis.","volume":"6","author":"I Vliegen","year":"2004","journal-title":"Microbes Infect"},{"key":"ref62","first-page":"739","article-title":"Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.","volume":"140","author":"TC Wu","year":"1992","journal-title":"Am J Pathol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1001\/jama.1989.03420240075030","article-title":"Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.","volume":"261","author":"MT Grattan","year":"1989","journal-title":"JAMA"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.","volume":"365","author":"EM Hodson","year":"2005","journal-title":"Lancet"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00007890-200203150-00005","article-title":"Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.","volume":"73","author":"SL Orloff","year":"2002","journal-title":"Transplantation"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/JVI.77.3.2182-2194.2003","article-title":"Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.","volume":"77","author":"DN Streblow","year":"2003","journal-title":"J Virol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2009-12-257832","article-title":"Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction.","volume":"116","author":"A Fantin","year":"2010","journal-title":"Blood"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1073\/pnas.81.19.6134","article-title":"Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.","volume":"81","author":"GP Rice","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref69","first-page":"2701","article-title":"Cytomegaloviruses.","author":"ES Mocarski Jr","year":"2007"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/infdis\/173.1.240","article-title":"Tissue macrophages are infected by human cytomegalovirus in vivo.","volume":"173","author":"C Sinzger","year":"1996","journal-title":"J Infect Dis"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1128\/JVI.73.7.5970-5980.1999","article-title":"Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.","volume":"73","author":"LK Hanson","year":"1999","journal-title":"J Virol"},{"key":"ref72","first-page":"58","article-title":"Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat.","volume":"Suppl 99","author":"G Steinhoff","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/0008-5472.CAN-08-2487","article-title":"The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.","volume":"69","author":"D Maussang","year":"2009","journal-title":"Cancer Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(00)81539-1","article-title":"The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.","volume":"99","author":"DN Streblow","year":"1999","journal-title":"Cell"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"e1000304","DOI":"10.1371\/journal.ppat.1000304","article-title":"Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.","volume":"5","author":"J Vomaske","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1128\/JVI.02113-10","article-title":"Partial functional complementation between human and mouse cytomegalovirus receptor homologues.","volume":"85","author":"HE Farrell","year":"2011","journal-title":"J Virol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.0000084505.54603.C7","article-title":"Human cytomegalovirus seropositivity is associated with impaired vascular function.","volume":"108","author":"C Grahame-Clarke","year":"2003","journal-title":"Circulation"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1099\/vir.0.81955-0","article-title":"Human cytomegalovirus-induced reduction of extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in vasculopathies?","volume":"87","author":"B Reinhardt","year":"2006","journal-title":"J Gen Virol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/cyto.2002.0874","article-title":"The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production.","volume":"19","author":"JR Randolph-Habecker","year":"2002","journal-title":"Cytokine"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1099\/vir.0.80327-0","article-title":"Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus.","volume":"86","author":"B Reinhardt","year":"2005","journal-title":"J Gen Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"e3381","DOI":"10.1371\/journal.pone.0003381","article-title":"Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development.","volume":"3","author":"DS Dace","year":"2008","journal-title":"PLoS One"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature05571","article-title":"DII4 signalling through Notch1 regulates formation of tip cells during angiogenesis.","volume":"445","author":"M Hellstrom","year":"2007","journal-title":"Nature"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/JVI.00864-07","article-title":"Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes.","volume":"82","author":"G Chan","year":"2008","journal-title":"J Virol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1386-6532(02)00087-2","article-title":"Mouse models of cytomegalovirus latency: overview.","volume":"25","author":"MJ Reddehase","year":"2002","journal-title":"J Clin Virol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199204303261803","article-title":"A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.","volume":"326","author":"TC Merigan","year":"1992","journal-title":"N Engl J Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.","volume":"100","author":"HA Valentine","year":"1999","journal-title":"Circulation"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0041-1345(00)02686-5","article-title":"Cytomegalovirus infection-enhanced chronic rejection in the rat is prevented by antiviral prophylaxis.","volume":"33","author":"J Tikkanen","year":"2001","journal-title":"Transplant Proc"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.TP.0000137334.46155.94","article-title":"Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats.","volume":"79","author":"H Zeng","year":"2005","journal-title":"Transplantation"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/02713689408999892","article-title":"Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis.","volume":"13","author":"RD Dix","year":"2005","journal-title":"Curr Eye Res"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.exer.2004.10.008","article-title":"Gender and estrogen supplementation increases severity of experimental choroidal neovascularization.","volume":"80","author":"DG Espinosa-Heidmann","year":"2005","journal-title":"Exp Eye Res"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T02:50:08Z","timestamp":1594090208000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002671"}},"subtitle":[],"editor":[{"given":"Chris A.","family":"Benedict","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,26]]},"references-count":90,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002671","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,26]]}}}